Thermo Fisher Scientific Inc. (NYSE:TMO)’s share price gapped up prior to trading on Thursday . The stock had previously closed at $154.27, but opened at $154.80. Thermo Fisher Scientific shares last traded at $157.59, with a volume of 850,724 shares changing hands.

Several brokerages have recently issued reports on TMO. Zacks Investment Research upgraded Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $164.00 price target on the stock in a research note on Tuesday, May 3rd. Mizuho reiterated a “buy” rating and issued a $163.00 price target (up previously from $160.00) on shares of Thermo Fisher Scientific in a research note on Tuesday, May 3rd. Leerink Swann reiterated a “buy” rating on shares of Thermo Fisher Scientific in a research note on Saturday, April 30th. Morgan Stanley reiterated a “buy” rating on shares of Thermo Fisher Scientific in a research note on Saturday, April 30th. Finally, Jefferies Group downgraded Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a report on Friday, April 29th. Three research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $155.43.

The firm has a market capitalization of $62.07 billion and a PE ratio of 31.74. The firm has a 50-day moving average of $150.24 and a 200-day moving average of $141.71.

Thermo Fisher Scientific (NYSE:TMO) last released its earnings results on Thursday, April 28th. The company reported $1.80 earnings per share for the quarter, beating analysts’ consensus estimates of $1.74 by $0.06. The firm had revenue of $4.29 billion for the quarter, compared to analysts’ expectations of $4.11 billion. The firm’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same quarter last year, the firm posted $1.63 EPS. On average, equities research analysts predict that Thermo Fisher Scientific Inc. will post $8.13 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Monday, October 17th. Investors of record on Thursday, September 15th will be paid a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.38%. The ex-dividend date of this dividend is Tuesday, September 13th.

In related news, VP Peter M. Wilver sold 68,200 shares of Thermo Fisher Scientific stock in a transaction on Friday, June 10th. The shares were sold at an average price of $152.38, for a total transaction of $10,392,316.00. Following the transaction, the vice president now owns 64,727 shares in the company, valued at approximately $9,863,100.26. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, SVP Thomas W. Loewald sold 8,025 shares of Thermo Fisher Scientific stock in a transaction on Wednesday, July 13th. The shares were sold at an average price of $155.00, for a total transaction of $1,243,875.00. Following the transaction, the senior vice president now owns 52,194 shares in the company, valued at approximately $8,090,070. The disclosure for this sale can be found here.

A number of hedge funds recently made changes to their positions in TMO. Beach Investment Counsel Inc. PA increased its stake in shares of Thermo Fisher Scientific by 16.1% in the fourth quarter. Beach Investment Counsel Inc. PA now owns 108,482 shares of the company’s stock worth $15,388,000 after buying an additional 15,035 shares in the last quarter. TD Asset Management Inc. increased its stake in shares of Thermo Fisher Scientific by 13.1% in the fourth quarter. TD Asset Management Inc. now owns 514,828 shares of the company’s stock worth $73,028,000 after buying an additional 59,745 shares in the last quarter. Sandy Spring Bank increased its stake in shares of Thermo Fisher Scientific by 15.4% in the fourth quarter. Sandy Spring Bank now owns 8,848 shares of the company’s stock worth $1,255,000 after buying an additional 1,181 shares in the last quarter. Rockefeller Financial Services Inc. increased its stake in shares of Thermo Fisher Scientific by 1.2% in the fourth quarter. Rockefeller Financial Services Inc. now owns 16,417 shares of the company’s stock worth $2,328,000 after buying an additional 194 shares in the last quarter. Finally, First Trust Advisors LP increased its stake in shares of Thermo Fisher Scientific by 51.8% in the fourth quarter. First Trust Advisors LP now owns 276,223 shares of the company’s stock worth $39,182,000 after buying an additional 94,302 shares in the last quarter.

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.